156 related articles for article (PubMed ID: 28634489)
1. A Study of Patients with Primary Mediastinal Germ Cell Tumors Treated Using Multimodal Therapy.
Tanaka Y; Okamura T; Nagai T; Kobayashi D; Kobayashi T; Akita H; Moritoki Y; Yasui T
Adv Urol; 2017; 2017():1404610. PubMed ID: 28634489
[TBL] [Abstract][Full Text] [Related]
2. [Treatment of non-testicular germ cell tumors in children and adolescents with BEP and VIP: initial results of the MAKEI 89 therapy study].
Göbel U; Bamberg M; Engert J; Gnekow AK; Haas HJ; Jürgens H; Kühl J; Lenard HG; Lumenta C; Niethammer D
Klin Padiatr; 1991; 203(4):236-45. PubMed ID: 1719267
[TBL] [Abstract][Full Text] [Related]
3. Mediastinal germ cell tumours: where we are and where we are going-a narrative review.
Marandino L; Vogl UM
Mediastinum; 2022; 6():7. PubMed ID: 35340835
[TBL] [Abstract][Full Text] [Related]
4. Intensive induction-sequential chemotherapy with BOP/VIP-B compared with treatment with BEP/EP for poor-prognosis metastatic nonseminomatous germ cell tumor: a Randomized Medical Research Council/European Organization for Research and Treatment of Cancer study.
Kaye SB; Mead GM; Fossa S; Cullen M; deWit R; Bodrogi I; van Groeningen C; Sylvester R; Collette L; Stenning S; De Prijck L; Lallemand E; deMulder P
J Clin Oncol; 1998 Feb; 16(2):692-701. PubMed ID: 9469359
[TBL] [Abstract][Full Text] [Related]
5. Successful treatment of mixed yolk sac tumor and mature teratoma in the spinal cord: case report.
Mukasa A; Yanagisawa S; Saito K; Tanaka S; Takai K; Shibahara J; Ikegami M; Nakao Y; Takeshita K; Matsutani M; Saito N
J Neurosurg Spine; 2017 Mar; 26(3):319-324. PubMed ID: 27911225
[TBL] [Abstract][Full Text] [Related]
6. Regional deep hyperthermia for salvage treatment of children and adolescents with refractory or recurrent non-testicular malignant germ-cell tumours: an open-label, non-randomised, single-institution, phase 2 study.
Wessalowski R; Schneider DT; Mils O; Friemann V; Kyrillopoulou O; Schaper J; Matuschek C; Rothe K; Leuschner I; Willers R; Schönberger S; Göbel U; Calaminus G;
Lancet Oncol; 2013 Aug; 14(9):843-52. PubMed ID: 23823158
[TBL] [Abstract][Full Text] [Related]
7. The impact of bleomycin on retroperitoneal histology at post-chemotherapy retroperitoneal lymph node dissection of good risk germ cell tumors.
Cary KC; Pedrosa JA; Kaimakliotis HZ; Masterson TA; Einhorn LH; Foster RS
J Urol; 2015 Feb; 193(2):507-12. PubMed ID: 25254937
[TBL] [Abstract][Full Text] [Related]
8. [Treatment of metastatic seminoma by chemotherapy.: an experience].
Komatsubara S; Itoi T; Watanabe M; Kitamura Y; Koike T
Nihon Hinyokika Gakkai Zasshi; 2000; 91(10-11):666-72. PubMed ID: 11109817
[TBL] [Abstract][Full Text] [Related]
9. [Treatment of metastatic germ cell tumors with etoposide and cisplatin as first line chemotherapy].
Shintaku I; Numahata K; Suzuki K; Ohyama C; Sato M; Saito S; Hoshi S; Orikasa S
Nihon Hinyokika Gakkai Zasshi; 2002 May; 93(4):519-24. PubMed ID: 12056035
[TBL] [Abstract][Full Text] [Related]
10. Prognostic analysis of Japanese men with metastatic germ cell tumors showing favorable response to bleomycin, etoposide and cisplatin as first-line chemotherapy.
Kumano M; Miyake H; Hara I; Muramaki M; Takenaka A; Fujisawa M
Hinyokika Kiyo; 2007 Dec; 53(12):851-6. PubMed ID: 18203521
[TBL] [Abstract][Full Text] [Related]
11. Primary mediastinal germ cell tumours: real world experience in the low middle income (LMIC) setting.
Joel A; Mathew N; Andugala SS; Daniel S; Gnanamuthu BR; John AO; Georgy JT; Chacko RT; Irodi A; Yadav B; John S; Singh A
Ecancermedicalscience; 2021; 15():1186. PubMed ID: 33777179
[TBL] [Abstract][Full Text] [Related]
12. Randomized comparison of cisplatin and etoposide and either bleomycin or ifosfamide in treatment of advanced disseminated germ cell tumors: an Eastern Cooperative Oncology Group, Southwest Oncology Group, and Cancer and Leukemia Group B Study.
Nichols CR; Catalano PJ; Crawford ED; Vogelzang NJ; Einhorn LH; Loehrer PJ
J Clin Oncol; 1998 Apr; 16(4):1287-93. PubMed ID: 9552027
[TBL] [Abstract][Full Text] [Related]
13. Salvage therapy in recurrent germ cell cancer: ifosfamide and cisplatin plus either vinblastine or etoposide.
Loehrer PJ; Lauer R; Roth BJ; Williams SD; Kalasinski LA; Einhorn LH
Ann Intern Med; 1988 Oct; 109(7):540-6. PubMed ID: 2844110
[TBL] [Abstract][Full Text] [Related]
14. [Therapeutic evaluation of cisplatin, etoposide, and bleomycin chemotherapy regimen in high-risk gestational trophoblastic neoplasia].
Song SQ; Zhang GN
Zhonghua Fu Chan Ke Za Zhi; 2012 Aug; 47(8):571-6. PubMed ID: 23141175
[TBL] [Abstract][Full Text] [Related]
15. Delayed orchiectomy after chemotherapy in patients with advanced testicular cancer.
Ondrus D; Hornák M; Breza J; Mat'oska J; Schnorrer M; Belan V; Kausitz J
Int Urol Nephrol; 2001; 32(4):665-7. PubMed ID: 11989561
[TBL] [Abstract][Full Text] [Related]
16. Improved management of abdominal undescended testicular tumors with bulky confluent retroperitoneal nodal metastases.
Kulkarni JN; Desai SM; Phadke GK; Tongaonkar HB
J Urol; 1996 Oct; 156(4):1341-4. PubMed ID: 8808867
[TBL] [Abstract][Full Text] [Related]
17. Risk-adapted chemotherapy of germ cell tumors with carboplatin, etoposide and bleomycin for low-risk and cisplatin, etoposide and ifosfamide for high-risk patients. A single-center study.
Tscherry G; Jacky E; Jost LM; Stahel RA
Oncology; 2000 Aug; 59(2):110-7. PubMed ID: 10971168
[TBL] [Abstract][Full Text] [Related]
18. Multimodal Treatment of Extragonadal Choriocarcinoma with Multiple Brain and Lung Metastases: A Case Report.
Uematsu M; Kanemasa Y; Nakamura S; Funasaka C; Kageyama A; Shimoyama T; Omuro Y
Case Rep Oncol; 2019; 12(3):928-934. PubMed ID: 32110211
[TBL] [Abstract][Full Text] [Related]
19. [A case of primary mediastinal choriocarcinoma].
Yamane T; Egawa H; Deguchi N; Moritani C
Nihon Kokyuki Gakkai Zasshi; 2006 Jan; 44(1):48-54. PubMed ID: 16502867
[TBL] [Abstract][Full Text] [Related]
20. Combination chemotherapy with vinblastine, bleomycin, cisplatin, and etoposide (VBPE) in children with primary intracranial germ cell tumors.
Chang TK; Wong TT; Hwang B
Med Pediatr Oncol; 1995 Jun; 24(6):368-72. PubMed ID: 7536294
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
